Literature DB >> 6341485

Assessment of the virulence factors of group B streptococci: correlation with sialic acid content.

A O Shigeoka, N S Rote, J I Santos, H R Hill.   

Abstract

Previous studies demonstrated strain-specific differences in opsonic requirements and virulence in neonatal rats among organisms of the same serotype of group B streptococci. The present study investigated the role of sialic acid cell-surface determinants in differences in virulence. Serotype III strains resistant to opsonization by antibody-containing sera had a higher percentage of cellular sialic acid than other organisms (1.02% sialic acid for four type III resistant strains versus 0.59% for three type III sensitive strains; P less than 0.01). Neuraminidase removed up to 70% of the extractable sialic acid from serotype III strains, markedly decreased their virulence, and made them more sensitive to the effects of protective antibody. No differences in sialic acid content were detected between sensitive and resistant strains of serotype II, and neuraminidase did not significantly remove sialic acid or affect their virulence. The present studies suggest differences in the nature or mode of attachment of virulence factors between types II and III of group B streptococci.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6341485     DOI: 10.1093/infdis/147.5.857

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  22 in total

1.  Opsonic effect of jacalin and human immunoglobulin A on type II group B streptococci.

Authors:  N R Payne; N F Concepcion; B F Anthony
Journal:  Infect Immun       Date:  1990-11       Impact factor: 3.441

2.  Deposition and degradation of C3 on type III group B streptococci.

Authors:  J R Campbell; C J Baker; M S Edwards
Journal:  Infect Immun       Date:  1991-06       Impact factor: 3.441

3.  Transposon mutagenesis of type III group B Streptococcus: correlation of capsule expression with virulence.

Authors:  C E Rubens; M R Wessels; L M Heggen; D L Kasper
Journal:  Proc Natl Acad Sci U S A       Date:  1987-10       Impact factor: 11.205

4.  Sialylation of group B streptococcal capsular polysaccharide is mediated by cpsK and is required for optimal capsule polymerization and expression.

Authors:  D O Chaffin; L M Mentele; C E Rubens
Journal:  J Bacteriol       Date:  2005-07       Impact factor: 3.490

5.  Molecular analysis of a region of the group B streptococcus chromosome involved in type III capsule expression.

Authors:  J M Kuypers; L M Heggen; C E Rubens
Journal:  Infect Immun       Date:  1989-10       Impact factor: 3.441

6.  Possible virulence marker for Streptococcus agalactiae (Lancefield Group B).

Authors:  G Orefici; S Recchia; L Galante
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1988-04       Impact factor: 3.267

7.  Guanidine extraction enhances the binding of human fibrinogen to group-B streptococci.

Authors:  G S Chhatwal; C Lämmler; H Blobel
Journal:  Med Microbiol Immunol       Date:  1984       Impact factor: 3.402

8.  Type-specific capsular antigen is associated with virulence in late-onset group B Streptococcal type III disease.

Authors:  M E Klegerman; K M Boyer; C K Papierniak; L Levine; S P Gotoff
Journal:  Infect Immun       Date:  1984-04       Impact factor: 3.441

Review 9.  The interplay between Siglecs and sialylated pathogens.

Authors:  Yung-Chi Chang; Victor Nizet
Journal:  Glycobiology       Date:  2014-07-04       Impact factor: 4.313

10.  Effect of differences in antibody and complement requirements on phagocytic uptake and intracellular killing of "c" protein-positive and -negative strains of type II group B streptococci.

Authors:  N R Payne; Y K Kim; P Ferrieri
Journal:  Infect Immun       Date:  1987-05       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.